New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
11:33 EDTAPOL, SVU, INFY, MU, PCYCOptions with decreasing implied volatility: APOL SVU INFY MU PCYC
News For APOL;SVU;INFY;MU;PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 24, 2014
05:42 EDTMUMicron management to meet with JMP Securities
Meeting to be held in San Francisco on October 24 hosted by JMP Securities.
October 23, 2014
17:14 EDTMUMicron recommends shareholders reject TRC Capital's 'mini-tender' offer
Subscribe for More Information
October 22, 2014
10:03 EDTMUThe Linley Group to hold a conference
Subscribe for More Information
October 21, 2014
12:11 EDTMUEinhorn says bought some Micron back last week, trimmed at higher levels
David Einhorn of Greenlight Capital is speaking on CNBC.
10:42 EDTMUMicron recommended as long idea by Tilson, Bloomberg reports
Subscribe for More Information
07:34 EDTAPOLApollo Education sees 1Q15 revenue $720M-$730M, consensus $763.70M
Subscribe for More Information
07:33 EDTAPOLApollo Education sees FY15 revenue $2.8B-$2.85B, consensus $2.80B
07:32 EDTAPOLApollo reports Q4 University of Phoenix New Degreed Enrollment down 5.9%
Subscribe for More Information
07:31 EDTAPOLApollo Education reports Q4 EPS from cont. ops. ex-items 34c, consensus 27c
Subscribe for More Information
October 20, 2014
18:51 EDTMUOn The Fly: After Hours Movers
Subscribe for More Information
12:36 EDTMUOptions with decreasing implied volatility
Subscribe for More Information
08:14 EDTPCYCPharmacyclics files supplmeental NDA for Imbruvica for macroglobulinemia
Pharmacyclics (PCYC) announced that it has submitted a supplemental New Drug Application to the FDA based on data from a Phase 2 study evaluating the use of IMBRUVICA in patients with Waldenstrom's macroglobulinemia. IMBRUVICA, which received FDA Breakthrough Therapy Designation in February 2013 for patients with WM, is being jointly developed and commercialized by Pharmacyclics and Janssen Biotech (JNJ).
06:53 EDTMUMicron upgraded to Outperform from Sector Perform at Pacific Crest
Subscribe for More Information
05:58 EDTMUMicron upgraded to Outperform from Sector Perform at Pacific Crest
October 17, 2014
11:51 EDTMUStocks with call strike movement; MU DAL
Subscribe for More Information
09:16 EDTMUMicron management to meet with MKM Partners
Meetings to be held in New York on October 23 and in the Mid-Atlantic area on October 24 hosted by MKM Partners.
08:57 EDTPCYCPharmacyclics price target raised to $188 from $185 at Roth Capital
Subscribe for More Information
08:51 EDTPCYCPharmacyclics announces European approval for Imbruvica
Subscribe for More Information
08:34 EDTPCYCPharmacyclics management to meet with JPMorgan
Subscribe for More Information
07:31 EDTMUSamsung first to market with new multilayer NAND technology, Nikkei says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use